Skip to main content

Closed

MNPR: Monopar Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-13.8%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio56.04×

Monopar Therapeutics Inc.

MNPRNASDAQ·USD·Closed

Monopar Therapeutics Inc.

MNPRNASDAQ·USD·Closed

$108.35

−5.50%

$108.35

−$6.31 (5.50%)

52W Range

90thpctl

Volume

2.12×avg

Mkt Cap

725.84MUSD

P/E

-55.4TTM

Div Yield

–ann

52W Range

90thpctl

Volume

2.12×avg

Market Cap

725.84MUSD

P/E Ratio

-55.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings